Gene Modified T Cell Therapies for Hematological Malignancies

被引:5
|
作者
Abramowski-Mock, Ulrike [1 ]
Delhove, Juliette M. [1 ]
Qasim, Waseem [1 ]
机构
[1] UCL, Mol & Cellular Immunol Unit, UCL Great Ormond St Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England
基金
“创新英国”项目;
关键词
Gene therapy; Gene editing; Adoptive immunotherapy; T cell receptor; Chimeric antigen receptor; Lentiviral vectors; Leukemia; Lymphoma; CHIMERIC-ANTIGEN-RECEPTOR; ACUTE MYELOID-LEUKEMIA; ZINC-FINGER NUCLEASES; B-CELL; CANCER-IMMUNOTHERAPY; ADOPTIVE IMMUNOTHERAPY; IMMUNE CHECKPOINTS; MULTIPLE-MYELOMA; CLINICAL-TRIAL; LYMPHOCYTES;
D O I
10.1016/j.hoc.2017.06.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This article focuses on clinical applications of T cells transduced to express recombinant T-cell receptor and chimeric antigen receptor constructs directed toward hematological malignancies, and considers newer strategies incorporating gene-editing technologies to address graft-versus-host disease and host-mediated rejection. Recent data from clinical trials are reviewed, and an overview is provided of current and emerging manufacturing processes; consideration is also given to new developments in the pipeline.
引用
收藏
页码:913 / +
页数:15
相关论文
共 50 条
  • [21] Erratum to: CAR T Cell Therapy for Hematological Malignancies
    Xin Yang
    Gao-xiang Wang
    Jian-feng Zhou
    Current Medical Science, 2021, 41 : 187 - 187
  • [22] CAR T-Cell Therapy in Hematological Malignancies
    Haslauer, Theresa
    Greil, Richard
    Zaborsky, Nadja
    Geisberger, Roland
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [23] T cell senescence and CAR-T cell exhaustion in hematological malignancies
    Kasakovski, Dimitri
    Xu, Ling
    Li, Yangqiu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [24] T cell senescence and CAR-T cell exhaustion in hematological malignancies
    Dimitri Kasakovski
    Ling Xu
    Yangqiu Li
    Journal of Hematology & Oncology, 11
  • [25] Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors
    Fujiwara, Hiroshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (02) : 123 - 131
  • [26] Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors
    Hiroshi Fujiwara
    International Journal of Hematology, 2014, 99 : 123 - 131
  • [27] T Cell Exhaustion and CAR-T Immunotherapy in Hematological Malignancies
    Tang, Lu
    Zhang, Yinqiang
    Hu, Yu
    Mei, Heng
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [28] Histone deacetylases and epigenetic therapies of hematological malignancies
    Mercurio, Ciro
    Minucci, Saverio
    Pelicci, Pier Giuseppe
    PHARMACOLOGICAL RESEARCH, 2010, 62 (01) : 18 - 34
  • [29] Epigenetically - Targeted Therapies for the Treatment of Hematological Malignancies
    Georgiou, E.
    Kouidou, S.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (12) : 1757 - 1764
  • [30] Antibody-directed therapies for hematological malignancies
    Linenberger, ML
    Maloney, DG
    Bernstein, ID
    TRENDS IN MOLECULAR MEDICINE, 2002, 8 (02) : 69 - 76